Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 158,498 shares at $75.11 ($11.9M) on 2025-10-31, disclosed to the SEC on 2025-11-03.
Scheduled sale ($11.9M) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.11 | 20,000 | $1.5M | 12.6% |
| 2 | $75.11 | 34,585 | $2.6M | 21.8% |
| 3 | $75.11 | 34,585 | $2.6M | 21.8% |
| 4 | $75.11 | 34,664 | $2.6M | 21.9% |
| 5 | $75.11 | 34,664 | $2.6M | 21.9% |
| Total | $75.11 avg | 158,498 |
| $11.9M |
| 100% |
| Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |
| IONS | SELL | 2025-08-06 | $429K | — | Filing → |